Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs
Authors:
- Claudia AlteriCAClaudia Alteri
- Valentina SvicherVSValentina Svicher
- Caterina GoriCGCaterina Gori
- Roberta D'ARrigoRDRoberta D'ARrigo
- Massimo CiccozziMCMassimo Ciccozzi
- Francesca Ceccherini-SilbersteinFCFrancesca Ceccherini-Silberstein
- Marina SelleriMSMarina Selleri
- Stefano Aviani BardacciSBStefano Aviani Bardacci
- Massimo GiulianiMGMassimo Giuliani
- Paola EliaPEPaola Elia
- Paola ScognamiglioPSPaola Scognamiglio
- Roberta BalzanoRBRoberta Balzano
Open Access
- 16 July 2009
- journal article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 9 (1) , 111
Abstract
Background: The transmission of HIV-1 drug-resistant strains in drug naive patients may seriously compromise the efficacy of a first-line antiretroviral treatment. To better define this problem, a study in a cohort of newly diagnosed HIV-1 infected individuals has been conducted. This study is aimed to assess the prevalence and the patterns of the mutations recently associated with transmitted drug resistance in the reverse transcriptase (RT) and in protease (PR) of HIV-1.Methods: Prevalence of transmitted drug resistant strains is determined in 255 newly diagnosed HIV-1 infected patients enrolled in different counselling and testing (CT) centres in Central Italy; the Avidity Index (AI) on the first available serum sample is also used to estimate time since infection. Logistic regression models are used to determine factors associated with infection by drug resistant HIV-1 strains.Results: The prevalence of HIV-1 strains with at least one major drug resistance mutation is 5.9% (15/255); moreover, 3.9% (10/255) of patients is infected with HIV nucleoside reverse transcriptase inhibitor (NRTI)-resistant viruses, 3.5% (9/255) with HIV non-NRTI-resistant viruses and 0.4% (1/255) with HIV protease inhibitor (PI)-resistant viruses. Most importantly, almost half (60.0%) of patients carries HIV-1 resistant strains with more than one major drug resistance mutation. In addition, patients who had acquired HIV through homosexual intercourses are more likely to harbour a virus with at least one primary resistance mutation (OR 7.7; 95% CI: 1.7–35.0, P = 0.008).Conclusion: The prevalence of drug resistant HIV-1 strains among newly diagnosed individuals in Central Italy is consistent with the data from other European countries. Nevertheless, the presence of drug-resistance HIV-1 mutations in complex patterns highlights an additional potential risk for public health and strongly supports the extension of wide genotyping to newly diagnosed HIV-1 infected patients.Keywords
This publication has 34 references indexed in Scilit:
- Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapyAIDS, 2008
- Low prevalence of transmitted antiretroviral drug resistance in a large UK HIV-1 cohortJournal of Antimicrobial Chemotherapy, 2008
- Persistence of Transmitted Drug Resistance among Subjects with Primary Human Immunodeficiency Virus InfectionJournal of Virology, 2008
- Ageing with HIV: newly diagnosed older adults in ItalyAIDS Care, 2008
- Detection of recent HIV infections in African individuals infected by HIV-1 non-B subtypes using HIV antibody avidityJournal of Clinical Virology, 2008
- HIV-1 protease and reverse transcriptase mutations for drug resistance surveillanceAIDS, 2007
- Involvement of Novel Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutations in the Regulation of Resistance to Nucleoside InhibitorsJournal of Virology, 2006
- Estimating HIV‐1 Drug Resistance in Antiretroviral‐Treated Individuals in the United KingdomThe Journal of Infectious Diseases, 2005
- Prevalence of Antiretroviral Drug Resistance Mutations in Chronically HIV-Infected, Treatment-Naive Patients: Implications for Routine Resistance Screening before Initiation of Antiretroviral TherapyClinical Infectious Diseases, 2005
- CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choiceNucleic Acids Research, 1994